Effect of use Vitamin D3?? ??for outcome in pertrochanteric patient in Valiasr hospital

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016102620258N15

Enrollment

100

Registered

2016-12-06

Start date

2016-08-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pertrochanteric. Pertrochanteric fracture

Interventions

Intervention 1: Control group have normal vitamin D3 and we injected 5000 IU vitamin D for ?them. We checked two groups ?improving wound and improving fracture (clinics and ?radiologic) and mortality

Treatment - Drugs

Control group have normal vitamin D3 and we injected 5000 IU vitamin D for ?them. We checked two groups ?improving wound and improving fracture (clinics and ?radiologic) and mortality. ?We checked th

Intervention group have not normal vitamin D3 .we injected 5000 IU vitamin D for ?them and we injected 5000 IU vitamin D every week to 12 week after surgery. We checked two groups ?improving wound and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: low-energy trauma such as a fall; visit in Valiasr hospital; age 60 and more Exclusion criteria: lack of follow-up; death

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improving wound. Timepoint: ?After surgery. Method of measurement: Clinical observation.;Improving fracture. Timepoint: ?2 weeks after surgery and every month to observe union ?. Method of measurement: Clinical observation and radiologic graphy.;Mortality. Timepoint: 6 months after surgery. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hojat Hejazi

Arak University Of Medical Sciences

hejazi@gmail.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026